ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 30 filers reported holding ENOCHIAN BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,038 | -71.2% | 7,126 | -52.9% | 0.00% | – |
| Q1 2023 | $14,000 | +116566.7% | 15,138 | +35.3% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 11,186 | +5.9% | 0.00% | – |
| Q3 2022 | $19,000 | -5.0% | 10,565 | 0.0% | 0.00% | – |
| Q2 2022 | $20,000 | – | 10,565 | +105550.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 10 | -95.2% | 0.00% | – |
| Q2 2021 | $1,000 | -99.4% | 209 | -99.5% | 0.00% | – |
| Q1 2021 | $155,000 | +29.2% | 43,806 | +7.8% | 0.00% | – |
| Q4 2020 | $120,000 | +192.7% | 40,630 | +265.4% | 0.00% | – |
| Q3 2020 | $41,000 | -24.1% | 11,119 | -11.8% | 0.00% | – |
| Q2 2020 | $54,000 | -18.2% | 12,607 | -43.2% | 0.00% | – |
| Q1 2020 | $66,000 | -32.0% | 22,199 | +15.6% | 0.00% | – |
| Q4 2019 | $97,000 | +1285.7% | 19,197 | +1357.6% | 0.00% | – |
| Q3 2019 | $7,000 | +40.0% | 1,317 | +19.4% | 0.00% | – |
| Q2 2019 | $5,000 | -92.4% | 1,103 | -88.5% | 0.00% | – |
| Q1 2019 | $66,000 | – | 9,567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
| Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
| Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
| Ergoteles LLC | 47,984 | $238,000 | 0.01% |
| Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
| HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
| JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
| UBS Group AG | 260 | $1,000 | 0.00% |